PMC:7253235 / 12862-13539 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"448","span":{"begin":44,"end":52},"obj":"Species"},{"id":"449","span":{"begin":101,"end":109},"obj":"Species"},{"id":"450","span":{"begin":276,"end":284},"obj":"Species"},{"id":"451","span":{"begin":20,"end":34},"obj":"Disease"},{"id":"452","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"453","span":{"begin":124,"end":138},"obj":"Disease"},{"id":"454","span":{"begin":144,"end":161},"obj":"Disease"},{"id":"455","span":{"begin":186,"end":206},"obj":"Disease"},{"id":"456","span":{"begin":300,"end":314},"obj":"Disease"},{"id":"457","span":{"begin":325,"end":336},"obj":"Disease"},{"id":"458","span":{"begin":355,"end":358},"obj":"Disease"},{"id":"459","span":{"begin":415,"end":423},"obj":"Disease"},{"id":"460","span":{"begin":457,"end":468},"obj":"Disease"},{"id":"461","span":{"begin":542,"end":550},"obj":"Disease"},{"id":"462","span":{"begin":584,"end":601},"obj":"Disease"},{"id":"463","span":{"begin":615,"end":624},"obj":"Disease"}],"attributes":[{"id":"A448","pred":"tao:has_database_id","subj":"448","obj":"Tax:9606"},{"id":"A449","pred":"tao:has_database_id","subj":"449","obj":"Tax:9606"},{"id":"A450","pred":"tao:has_database_id","subj":"450","obj":"Tax:9606"},{"id":"A451","pred":"tao:has_database_id","subj":"451","obj":"MESH:D016638"},{"id":"A452","pred":"tao:has_database_id","subj":"452","obj":"MESH:C000657245"},{"id":"A453","pred":"tao:has_database_id","subj":"453","obj":"MESH:D009202"},{"id":"A454","pred":"tao:has_database_id","subj":"454","obj":"MESH:D012770"},{"id":"A455","pred":"tao:has_database_id","subj":"455","obj":"MESH:D006331"},{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"MESH:D009202"},{"id":"A457","pred":"tao:has_database_id","subj":"457","obj":"MESH:D009205"},{"id":"A458","pred":"tao:has_database_id","subj":"458","obj":"MESH:D002318"},{"id":"A459","pred":"tao:has_database_id","subj":"459","obj":"MESH:C000657245"},{"id":"A460","pred":"tao:has_database_id","subj":"460","obj":"MESH:D009205"},{"id":"A461","pred":"tao:has_database_id","subj":"461","obj":"MESH:C000657245"},{"id":"A462","pred":"tao:has_database_id","subj":"462","obj":"MESH:D009202"},{"id":"A463","pred":"tao:has_database_id","subj":"463","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A case series of 21 critically ill COVID-19 patients from Seattle also found that one-third of their patients developed new cardiomyopathy with cardiogenic shock in the absence of prior systolic dysfunction during the progression of their illness [25]. It is unclear if these patients that developed cardiomyopathy truly had myocarditis or had underlying CVD that predisposed them to this clinical course. However, COVID-19 has been shown to directly cause myocarditis in otherwise healthy individuals in several case reports [30, 31]. Thus, COVID-19 demonstrates various patterns of myocardial injury, with higher mortality risk being associated with elevated troponin levels."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T21","span":{"begin":661,"end":669},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma62338"}],"text":"A case series of 21 critically ill COVID-19 patients from Seattle also found that one-third of their patients developed new cardiomyopathy with cardiogenic shock in the absence of prior systolic dysfunction during the progression of their illness [25]. It is unclear if these patients that developed cardiomyopathy truly had myocarditis or had underlying CVD that predisposed them to this clinical course. However, COVID-19 has been shown to directly cause myocarditis in otherwise healthy individuals in several case reports [30, 31]. Thus, COVID-19 demonstrates various patterns of myocardial injury, with higher mortality risk being associated with elevated troponin levels."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T139","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"T140","span":{"begin":124,"end":138},"obj":"Disease"},{"id":"T141","span":{"begin":300,"end":314},"obj":"Disease"},{"id":"T142","span":{"begin":325,"end":336},"obj":"Disease"},{"id":"T143","span":{"begin":415,"end":423},"obj":"Disease"},{"id":"T144","span":{"begin":457,"end":468},"obj":"Disease"},{"id":"T145","span":{"begin":542,"end":550},"obj":"Disease"},{"id":"T146","span":{"begin":595,"end":601},"obj":"Disease"}],"attributes":[{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0004994"},{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0004994"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0004496"},{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A144","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0004496"},{"id":"A145","pred":"mondo_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"A case series of 21 critically ill COVID-19 patients from Seattle also found that one-third of their patients developed new cardiomyopathy with cardiogenic shock in the absence of prior systolic dysfunction during the progression of their illness [25]. It is unclear if these patients that developed cardiomyopathy truly had myocarditis or had underlying CVD that predisposed them to this clinical course. However, COVID-19 has been shown to directly cause myocarditis in otherwise healthy individuals in several case reports [30, 31]. Thus, COVID-19 demonstrates various patterns of myocardial injury, with higher mortality risk being associated with elevated troponin levels."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T82","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T83","span":{"begin":424,"end":427},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"A case series of 21 critically ill COVID-19 patients from Seattle also found that one-third of their patients developed new cardiomyopathy with cardiogenic shock in the absence of prior systolic dysfunction during the progression of their illness [25]. It is unclear if these patients that developed cardiomyopathy truly had myocarditis or had underlying CVD that predisposed them to this clinical course. However, COVID-19 has been shown to directly cause myocarditis in otherwise healthy individuals in several case reports [30, 31]. Thus, COVID-19 demonstrates various patterns of myocardial injury, with higher mortality risk being associated with elevated troponin levels."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T78","span":{"begin":124,"end":138},"obj":"Phenotype"},{"id":"T79","span":{"begin":144,"end":161},"obj":"Phenotype"},{"id":"T80","span":{"begin":300,"end":314},"obj":"Phenotype"},{"id":"T81","span":{"begin":325,"end":336},"obj":"Phenotype"},{"id":"T82","span":{"begin":457,"end":468},"obj":"Phenotype"}],"attributes":[{"id":"A78","pred":"hp_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/HP_0001638"},{"id":"A79","pred":"hp_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/HP_0030149"},{"id":"A80","pred":"hp_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/HP_0001638"},{"id":"A81","pred":"hp_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/HP_0012819"},{"id":"A82","pred":"hp_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/HP_0012819"}],"text":"A case series of 21 critically ill COVID-19 patients from Seattle also found that one-third of their patients developed new cardiomyopathy with cardiogenic shock in the absence of prior systolic dysfunction during the progression of their illness [25]. It is unclear if these patients that developed cardiomyopathy truly had myocarditis or had underlying CVD that predisposed them to this clinical course. However, COVID-19 has been shown to directly cause myocarditis in otherwise healthy individuals in several case reports [30, 31]. Thus, COVID-19 demonstrates various patterns of myocardial injury, with higher mortality risk being associated with elevated troponin levels."}

{"project":"LitCovid-sentences","denotations":[{"id":"T80","span":{"begin":0,"end":252},"obj":"Sentence"},{"id":"T81","span":{"begin":253,"end":405},"obj":"Sentence"},{"id":"T82","span":{"begin":406,"end":535},"obj":"Sentence"},{"id":"T83","span":{"begin":536,"end":677},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A case series of 21 critically ill COVID-19 patients from Seattle also found that one-third of their patients developed new cardiomyopathy with cardiogenic shock in the absence of prior systolic dysfunction during the progression of their illness [25]. It is unclear if these patients that developed cardiomyopathy truly had myocarditis or had underlying CVD that predisposed them to this clinical course. However, COVID-19 has been shown to directly cause myocarditis in otherwise healthy individuals in several case reports [30, 31]. Thus, COVID-19 demonstrates various patterns of myocardial injury, with higher mortality risk being associated with elevated troponin levels."}